Ebolavirus Disease Available Phase Trials for Maftivimab (DB15899)

Also known as: Ebola Virus Disease

IndicationStatusPhase
DBCOND0073542 (Ebolavirus Disease)AvailableNot Available
clinicaltrials.gov IdentifierTitlePurposeDrugs
NCT03576690R3470-3471-3479 (REGN-EB3) Expanded Access Protocol (EAP) for Treatment of Ebola Virus Disease